CVE-2026-47896 Apache CVE debrief

Who should care

Users of Apache Lucene.Net.Replicator versions from 4.8.0-beta00005 through 4.8.0-beta00017 should be aware of this vulnerability and take steps to mitigate it. This includes reviewing inventory of affected systems, monitoring for potential exploitation attempts, and upgrading to version 4.8.0-beta00018 or later.

Technical summary

The CVE-2026-47896 vulnerability is caused by an improper limitation of a pathname to a restricted directory, also known as a Path Traversal vulnerability. This issue exists in the Apache Lucene.Net.Replicator library, affecting versions from 4.8.0-beta00005 through 4.8.0-beta00017. The vulnerability has a CVSS score of 8.9 and is classified as HIGH severity. Users should review their deployments, assess potential impact, and plan for upgrades or mitigations.

Defensive priority

High priority should be given to upgrading Apache Lucene.Net.Replicator to version 4.8.0-beta00018 or later to mitigate this vulnerability. Additionally, users should review their deployments, assess potential impact, and plan for upgrades or mitigations.

Recommended defensive actions

• Upgrade Apache Lucene.Net.Replicator to version 4.8.0-beta00018 or later
• Review and update inventory of affected systems
• Monitor for potential exploitation attempts
• Review compensating controls for exposed systems while remediation is scheduled and verified
• Check relevant monitoring, detection, and logs for exposed assets that need extra review
• Track exceptions, retest remediated assets, and close the item only after evidence is documented
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The CVE record was published on 2026-07-03T09:16:37.397Z and was last modified on 2026-07-08T15:04:21.570Z. The NVD entry is currently Analyzed. The Apache Lucene.Net.Replicator library is affected by a Path Traversal vulnerability, tracked as CVE-2026-47896. Users should verify their deployments and review official advisories for affected scope and vendor guidance.

Official resources